Summary information and primary citation

PDB-id
4zdo; SNAP-derived features in text and JSON formats; DNAproDB
Class
transferase-RNA
Method
X-ray (2.65 Å)
Summary
The crystal structure of t325s mutant of human sepsecs in complex with selenocysteine trna (trnasec)
Reference
Puppala AK, French RL, Matthies D, Baxa U, Subramaniam S, Simonovic M (2016): "Structural basis for early-onset neurological disorders caused by mutations in human selenocysteine synthase." Sci Rep, 6, 32563. doi: 10.1038/srep32563.
Abstract
Selenocysteine synthase (SepSecS) catalyzes the terminal reaction of selenocysteine, and is vital for human selenoproteome integrity. Autosomal recessive inheritance of mutations in SepSecS-Ala239Thr, Thr325Ser, Tyr334Cys and Tyr429*-induced severe, early-onset, neurological disorders in distinct human populations. Although harboring different mutant alleles, patients presented remarkably similar phenotypes typified by cerebellar and cerebral atrophy, seizures, irritability, ataxia, and extreme spasticity. However, it has remained unclear how these genetic alterations affected the structure of SepSecS and subsequently elicited the development of a neurological pathology. Herein, our biophysical and structural characterization demonstrates that, with the exception of Tyr429*, pathogenic mutations decrease protein stability and trigger protein misfolding. We propose that the reduced stability and increased propensity towards misfolding are the main causes for the loss of SepSecS activity in afflicted patients, and that these factors contribute to disease progression. We also suggest that misfolding of enzymes regulating protein synthesis should be considered in the diagnosis and study of childhood neurological disorders.

Cartoon-block schematics in six views (download the tarball)

PyMOL session file Download PDB file View in 3Dmol.js